At A Glance: This Prescriber in 2012
Self-Reported Primary Specialty
Rank: 55 out of 111
Rank: 44 out of 111
How Does This Prescriber Compare to Peers?
12% of this provider’s 115 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.
14% of this provider’s 115 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.
Risky Drugs to Seniors
3% of this provider’s 580 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.
Brand Name Drugs
21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.
$460 was the average price of a prescription from this provider, compared to $356 among peers.
Prescriptions per Patient
7 is the average number of prescriptions (including refills) per patient, compared to an average of 7.
This Prescriber's Drugs
Search for a Drug
5 questions to ask about a new drug »
via Consumer Health Choices
Compare different prescription drugs »
via Consumer Reports
Click to Filter by Category
This provider is among the top 10 prescribers of
this drug in the country.
This Drug's Rank
Total Prescriptions Filled
|Category||For this Prescriber||
For All Prescribers in
This Specialty in Wisconsin
Warfarin is used to prevent... +
Warfarin is used to prevent blood clots from forming or growing larger in your blood and blood vessels. It is prescribed for people with certain types of irregular heartbeat, people with prosthetic (replacement or mechanical) heart valves, and people who have suffered a heart attack. Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung). Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood. More info »
About This Data
- No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
- This provider's address and specialty information was last updated on July 7, 2010.